Skip to content

Company information lookup


Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PAB 0.035 2.94% 0.034 0.035 0.035 0.035 0.034 1,086,294


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PAB
Official Listing Date 13 July, 2007
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address
Registered Office Address Suite 614, Level 6 Equitable House, 343 Little Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (03) 9670 3273
Head Office Fax (03) 9670 3247
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr John Read (Non Exec. Chairman)
Dr Marie Roskrow (Managing Director, CEO)
Ms Suzy Jones (Non Exec. Director)
Mr Michael Stork (Non Exec. Director)
Mr Roger McPherson (CFO)
Company Secretary Mr Roger McPherson
Principal Activities Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.

PATRYS LIMITED announcements

How are company announcements published on

Date Price
Headline Pages PDF
11/04/2014 asterix Appendix 4C - Quarterly Cash Flow - March 2014 5 PDF
02/04/2014 asterix First Plant-based Production of PAT-SM6 2 PDF
27/03/2014 asterix Final Data Confirms Successful PAT-SM6 Clinical Trial 3 PDF
24/03/2014 asterix PAT-LM1 Advancing to the Clinic 2 PDF
18/03/2014   Share Issue and Cleansing Statement 13 PDF
12/02/2014 asterix Half Yearly Report and Accounts - December 2013 18 PDF
29/01/2014   Patrys Raises a Further $0.9 Million 13 PDF
23/01/2014 asterix Patrys Provides Shareholder Update 3 PDF
22/01/2014 asterix PAT-SC1 Clinical Trial 10 Year Follow Up Data Published 2 PDF
21/01/2014 asterix Appendix 4C - Quarterly Cash Flow - December 2013 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
23 Apr 2014 0.034 -5.56% 0.036 0.034 884,259
22 Apr 2014 0.036 0% 0.036 0.036 335,304
17 Apr 2014 0.036 0% 0.037 0.036 876,827
16 Apr 2014 0.036 2.86% 0.036 0.035 530,596
15 Apr 2014 0.035 2.94% 0.036 0.034 1,414,500

* Volume of shares shown represents only those shares traded on ASX.

PATRYS LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security PAB. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PAB

Warrants & Structured Products

No warrants & Structured Products are available over the security PAB


No Contracts For Differences are available over the security PAB